| Amanda Ortengren, DO | |
|
275 Sandwich St, Bid Plymouth Hospital, Plymouth, MA 02360-2183 | |
| (508) 746-2000 | |
| Not Available |
| Full Name | Amanda Ortengren |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 15 Years |
| Location | 275 Sandwich St, Plymouth, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407178494 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Vna Of Cape Cod | Hyannis, MA | Home health agency |
| Bayada Home Health Care , Inc | Hyannis, MA | Home health agency |
| Cape Cod Healthcare | Hyannis, MA | Hospital |
| Falmouth Hospital | Falmouth, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Affiliates Of Cape Cod Inc | 3577471564 | 190 |
| Physicians Of Cape Cod Hospital | 9638326671 | 261 |
News Archive
AVANIR Pharmaceuticals, Inc. today reported unaudited financial results for the three and six months ended March 31, 2010.
The European Society of Clinical Microbiology and Infectious Disease (ESCMID) – an organization that explores the risks and best practices in infectious disease – advocates the need for greater education, guidance and research on the build-up, treatment and prevention of biofilms, which contribute to antimicrobial resistance.
Students with disabilities and learning difficulties are taking part in a unique University of Liverpool training scheme that enables them to educate those with similar disabilities to themselves.
Corventis, Inc., a developer of wireless cardiovascular solutions, announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its NUVANT™ Mobile Cardiac Telemetry (MCT) System for the detection of non-lethal arrhythmias. In addition, the company announced that its Monitoring Center has been approved by the Center for Medicare & Medicaid Services (CMS) as an Independent Diagnostic Testing Facility (IDTF). Corventis has also received approval to bill for services provided to patients with Medicare and several commercial insurers, paving the way for the NUVANT MCT System to be available across the United States.
A study led by St. Jude Children's Research Hospital scientists has identified the population of white blood cells that tumors use to enhance growth and suppress the disease-fighting immune system.
› Verified 7 days ago
| Entity Name | Medical Affiliates Of Cape Cod Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770534927 PECOS PAC ID: 3577471564 Enrollment ID: O20040510001010 |
News Archive
AVANIR Pharmaceuticals, Inc. today reported unaudited financial results for the three and six months ended March 31, 2010.
The European Society of Clinical Microbiology and Infectious Disease (ESCMID) – an organization that explores the risks and best practices in infectious disease – advocates the need for greater education, guidance and research on the build-up, treatment and prevention of biofilms, which contribute to antimicrobial resistance.
Students with disabilities and learning difficulties are taking part in a unique University of Liverpool training scheme that enables them to educate those with similar disabilities to themselves.
Corventis, Inc., a developer of wireless cardiovascular solutions, announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its NUVANT™ Mobile Cardiac Telemetry (MCT) System for the detection of non-lethal arrhythmias. In addition, the company announced that its Monitoring Center has been approved by the Center for Medicare & Medicaid Services (CMS) as an Independent Diagnostic Testing Facility (IDTF). Corventis has also received approval to bill for services provided to patients with Medicare and several commercial insurers, paving the way for the NUVANT MCT System to be available across the United States.
A study led by St. Jude Children's Research Hospital scientists has identified the population of white blood cells that tumors use to enhance growth and suppress the disease-fighting immune system.
› Verified 7 days ago
| Entity Name | Beth Israel Deaconess Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548202641 PECOS PAC ID: 8123936119 Enrollment ID: O20041001000827 |
News Archive
AVANIR Pharmaceuticals, Inc. today reported unaudited financial results for the three and six months ended March 31, 2010.
The European Society of Clinical Microbiology and Infectious Disease (ESCMID) – an organization that explores the risks and best practices in infectious disease – advocates the need for greater education, guidance and research on the build-up, treatment and prevention of biofilms, which contribute to antimicrobial resistance.
Students with disabilities and learning difficulties are taking part in a unique University of Liverpool training scheme that enables them to educate those with similar disabilities to themselves.
Corventis, Inc., a developer of wireless cardiovascular solutions, announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its NUVANT™ Mobile Cardiac Telemetry (MCT) System for the detection of non-lethal arrhythmias. In addition, the company announced that its Monitoring Center has been approved by the Center for Medicare & Medicaid Services (CMS) as an Independent Diagnostic Testing Facility (IDTF). Corventis has also received approval to bill for services provided to patients with Medicare and several commercial insurers, paving the way for the NUVANT MCT System to be available across the United States.
A study led by St. Jude Children's Research Hospital scientists has identified the population of white blood cells that tumors use to enhance growth and suppress the disease-fighting immune system.
› Verified 7 days ago
| Entity Name | Physicians Of Cape Cod Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679832364 PECOS PAC ID: 9638326671 Enrollment ID: O20120828000193 |
News Archive
AVANIR Pharmaceuticals, Inc. today reported unaudited financial results for the three and six months ended March 31, 2010.
The European Society of Clinical Microbiology and Infectious Disease (ESCMID) – an organization that explores the risks and best practices in infectious disease – advocates the need for greater education, guidance and research on the build-up, treatment and prevention of biofilms, which contribute to antimicrobial resistance.
Students with disabilities and learning difficulties are taking part in a unique University of Liverpool training scheme that enables them to educate those with similar disabilities to themselves.
Corventis, Inc., a developer of wireless cardiovascular solutions, announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its NUVANT™ Mobile Cardiac Telemetry (MCT) System for the detection of non-lethal arrhythmias. In addition, the company announced that its Monitoring Center has been approved by the Center for Medicare & Medicaid Services (CMS) as an Independent Diagnostic Testing Facility (IDTF). Corventis has also received approval to bill for services provided to patients with Medicare and several commercial insurers, paving the way for the NUVANT MCT System to be available across the United States.
A study led by St. Jude Children's Research Hospital scientists has identified the population of white blood cells that tumors use to enhance growth and suppress the disease-fighting immune system.
› Verified 7 days ago
| Entity Name | Associated Physicians Of Harvard Medical Faculty Physicians At Beth Is |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497151773 PECOS PAC ID: 6305749987 Enrollment ID: O20150211001099 |
News Archive
AVANIR Pharmaceuticals, Inc. today reported unaudited financial results for the three and six months ended March 31, 2010.
The European Society of Clinical Microbiology and Infectious Disease (ESCMID) – an organization that explores the risks and best practices in infectious disease – advocates the need for greater education, guidance and research on the build-up, treatment and prevention of biofilms, which contribute to antimicrobial resistance.
Students with disabilities and learning difficulties are taking part in a unique University of Liverpool training scheme that enables them to educate those with similar disabilities to themselves.
Corventis, Inc., a developer of wireless cardiovascular solutions, announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its NUVANT™ Mobile Cardiac Telemetry (MCT) System for the detection of non-lethal arrhythmias. In addition, the company announced that its Monitoring Center has been approved by the Center for Medicare & Medicaid Services (CMS) as an Independent Diagnostic Testing Facility (IDTF). Corventis has also received approval to bill for services provided to patients with Medicare and several commercial insurers, paving the way for the NUVANT MCT System to be available across the United States.
A study led by St. Jude Children's Research Hospital scientists has identified the population of white blood cells that tumors use to enhance growth and suppress the disease-fighting immune system.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amanda Ortengren, DO 275 Sandwich St, Bid Plymouth Hospital, Plymouth, MA 02360-2183 Ph: () - | Amanda Ortengren, DO 275 Sandwich St, Bid Plymouth Hospital, Plymouth, MA 02360-2183 Ph: (508) 746-2000 |
News Archive
AVANIR Pharmaceuticals, Inc. today reported unaudited financial results for the three and six months ended March 31, 2010.
The European Society of Clinical Microbiology and Infectious Disease (ESCMID) – an organization that explores the risks and best practices in infectious disease – advocates the need for greater education, guidance and research on the build-up, treatment and prevention of biofilms, which contribute to antimicrobial resistance.
Students with disabilities and learning difficulties are taking part in a unique University of Liverpool training scheme that enables them to educate those with similar disabilities to themselves.
Corventis, Inc., a developer of wireless cardiovascular solutions, announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its NUVANT™ Mobile Cardiac Telemetry (MCT) System for the detection of non-lethal arrhythmias. In addition, the company announced that its Monitoring Center has been approved by the Center for Medicare & Medicaid Services (CMS) as an Independent Diagnostic Testing Facility (IDTF). Corventis has also received approval to bill for services provided to patients with Medicare and several commercial insurers, paving the way for the NUVANT MCT System to be available across the United States.
A study led by St. Jude Children's Research Hospital scientists has identified the population of white blood cells that tumors use to enhance growth and suppress the disease-fighting immune system.
› Verified 7 days ago
Gregory Joseph Robke, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 45 Resnik Road, Suite 302, Plymouth, MA 02360 Phone: 508-746-2696 Fax: 508-746-2695 | |
Dr. Irina Gurevich, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 275 Sandwich St, C/o Cathy Grey, Plymouth, MA 02360 Phone: 508-830-2390 Fax: 508-830-2399 | |
Maysaa El Zoghbi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 275 Sandwich St, Plymouth, MA 02360 Phone: 508-746-2000 | |
Baigalmaa Enkhtaivan, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 275 Sandwich St, Plymouth, MA 02360 Phone: 508-830-2679 Fax: 508-830-2702 | |
Senada Arabelovic, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 45 Resnik Rd, Plymouth, MA 02360 Phone: 508-746-5351 | |
Muhammad Mubarak, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 275 Sandwich St, Plymouth, MA 02360 Phone: 617-754-4677 | |
Katherine Murray Leisure, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 116 Court St, 3rd Floor, Plymouth, MA 02360 Phone: 508-746-2138 Fax: 508-746-2148 |